[Source]
INDIANAPOLIS, Sept. 11, 2012 – AIT Bioscience is pleased to announce that Dr. Ron Bowsher, an industry expert in bioanalysis of ligand binding assays, has partnered with the company as a senior research advisor bringing with him an impressive background in biotherapeutic drug research in both traditional pharmaceutical and the CRO industries.
“I am excited about my advisory role at AIT Bioscience, because I believe this organization is both highly innovative and customer-focused,” said Dr. Bowsher, who has a long and illustrious history in biotherapeutic research and is a pioneer in regulated bioanalysis of macromolecules.
“The AIT Bioscience team is dedicated to providing both innovative and quality services as demonstrated by their cutting-edge use of electronic lab notebooks. I’m looking forward to helping them grow and expand their services for bioanalysis of large molecules, in order to help clients achieve expedited, quality data”, he says. In his role as senior research advisor of ligand binding assays, Dr. Bowsher will advise on technical, regulatory, and business development matters related to ligand binding methods.
“Dr. Bowsher is a pioneer in our industry and we are honored to have him as an advisor to our management team. His demonstrated leadership in ligand binding assays opens our services to a broader pipeline of molecules, allowing more clinical and non-clinical studies to benefit from our fully integrated electronic laboratory documentation system,” said AIT Bioscience president Dr. Ron Shoup.
Dr. Bowsher brings more than 35 years experience in the pharmaceutical/biotech and contract research organization industries. He received a bachelor’s degree in chemistry from Indiana University and holds a master’s degree and doctorate in biochemistry from the Indiana University School of Medicine. He is an adjunct assistant professor of biochemistry and molecular biology at the IU School of Medicine. In addition to his new advisory role at AIT Bioscience, Dr. Bowsher maintains his robust consulting and laboratory businesses at B2S Consulting® (Indianapolis, IN), and B2S Labs (Shelbyville, IN), respectively. Since 1980 he has published more than 100 research papers and monographs and 105 abstracts. He holds three patents. He is an AAPS Fellow and was awarded an AAPS Presidential Citation for his work on establishing an educational program for ligand binding assays. In 2012, Dr. Bowsher received the Distinguished Alumnus Award, School of Science, Indiana University-Purdue University (IUPUI), Indianapolis IN.
About AIT Bioscience:
AIT Bioscience, LLC, headquartered in Indianapolis, Ind., is a bioanalytical contract research organization supporting pre-clinical and phase I-III clinical trials. AIT Bioscience provides robust analytical methods, automated sample logistics, with a systems-wide Quality by Design (QbD) operation that support programs through to the investigational new drug and new drug applications. AIT Bioscience has created a new standard for quantitative bioanalytical analysis and drug development in support of small biotech and large pharmaceutical companies. Learn more about AIT Bioscience at www.AITBioscience.com.
###
Media contact: Emilio Córdova, Ph.D., MBA, AIT Bioscience, 317-715-8800, [email protected]